Peripheral Artery Disease Clinical Trial
Official title:
Predicting the Clinical Outcomes of Patients With Lower Extremity Peripheral Arterial Disease Undergoing Endovascular Intervention Based on Computed Tomographic Angiography
Lower extremity peripheral artery disease (PAD), the third leading cause of atherosclerotic
cardiovascular morbidity following coronary artery disease and stroke, affect 200 million
people worldwide and is associated with high rates of cardiovascular events and death.
Consensus is reached on an "endovascular-first-strategy" for symptomatic PAD who have
developed critical limb ischemia.
However, the challenge of endovascular therapy is the long-term patency, and the associated
worse clinical outcomes, including higher rates of major adverse cardiovascular events, and
major adverse limb events. Meta-analysis concluded that restenosis occurred rate 5-70 % at 1
year; the incidence of adverse limb outcomes, (including worsening of symptoms, the need for
peripheral revascularization, and amputation) was 26% over a period of 4 years;
Cardiovascular morbidity and mortality up to 28 % after endovascular therapy.
There are no consensus guidelines on the optimal timing and the factor on adverse clinical
outcome remains uncertain. Therefore, the purpose of this study is to conduct a structured
surveillance plan for follow-up care and evaluate risk factors that will eventually support
development of a predictive model for clinical outcomes of endovascular procedures to treat
lower extremity PAD.
This is a prospective, observational, multi-center, clinical study examining predictors of
clinical outcomes for patients undergoing PAD endovascular treatment. The study population
will undergo lower extremity computed tomographic angiography (CTA )and endovascular
intervention procedures. CT scanning was performed with the coverage from the common iliac
artery bifurcation to the tiptoe, CTA data were transfer to an offline workstation for
further analysis. Axial images, cross-sectional views, curved planar reformations and
multiplane reformations, as well as three dimensional maximum intensity projection images
were available for evaluation. This includes disease in a vessel located proximal(involving
the aortoiliac and femoropopliteal locations), distal, (involving the infrapopliteal
location), proximal and distal (multilevel disease).
We conduct a detailed chart review to gather the data related to the index endovascular
intervention procedures report, study personnel history and physical presentation, laboratory
inspection, the lesion characteristics arising from CTA. Data abstract from chart review
include indication for procedure (intermittent claudication, rest pain, and tissue loss),
detailed lesion characteristics (lesion length, stenosis severity, diameter, and presence of
total occlusion), procedure(s) performed and devices used, and per procedural events.
Patients will be followed up for the occurrence of these outcomes from the time of their
initial revascularization procedure(1month after enrollment, and at months 3 (+- 2 weeks), 6
(+- 2 weeks), and 12 (+- 2 weeks)).
The follow-up of Clinical outcomes : Primary clinical outcomes of interest were :1)restenosis
in the treated segment(Restenosis was defined as a reduction in the luminal diameter of more
than 50 percent according to any imaging examinations such as duplex ultrasound, CTA,magnetic
resonance Imaging(MRI) or digital subtraction angiography(DSA) );2)re-intervention in the
treated segment for the clinical progression. Secondary end points included:1) all lower
extremity amputation, 2) all -cause death, myocardial infarction, and stroke; 3) a neo-
segment more than 75 % stenosis and clinical assessment requires intervention .
Cox proportional hazards models were created to show the hazard ratios (HRs) associated with
lesion characters and patient demographic and clinical characteristics ,and further identify
predictors of clinical outcomes, moreover, plotted unadjusted Kaplan Meier curves for lower
extremity peripheral artery patients undergone endovascular revascularization.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05712395 -
The Effects of a Novel, Non-ischemic and Pain-free Exercise Intervention in Peripheral Artery Disease
|
N/A | |
Active, not recruiting |
NCT04534257 -
Prospective Registry to Investigate the Safety and Efficacy of the Treatment With the Selution Sirolimus Drug Coated Balloon in TASC C and D Atheroma-occlusive Infra-Inguinal Disease in Patients With Chronic Limb Threatening Ischemia From Singapore
|
N/A | |
Recruiting |
NCT04511234 -
Sirolimus Coated Balloon Versus Standard Balloon for SFA and Popliteal Artery Disease
|
N/A | |
Recruiting |
NCT03506633 -
Impacts of Mitochondrial-targeted Antioxidant on Peripheral Artery Disease Patients
|
N/A | |
Active, not recruiting |
NCT03506646 -
Dietary Nitrate Supplementation and Thermoregulation
|
N/A | |
Completed |
NCT02554266 -
Registry Investigating the Clinical Use and Safety of the Lutonix Drug Coated Balloon for Treatment of BTK Arteries
|
||
Completed |
NCT03921905 -
Peripheral Artery Disease in Patients With Stable Coronary Artery Disease in General Practice: Prevalence, Management and Clinical Outcomes.
|
||
Not yet recruiting |
NCT06369350 -
Vitamin B6 on Exercise Pressor Reflex on Leg Ischemia-reperfusion
|
Early Phase 1 | |
Recruiting |
NCT04545268 -
Prehabilitation for Cardiac Surgery in Patients With Reduced Exercise Tolerance
|
N/A | |
Recruiting |
NCT02389023 -
Comparison of Prevena Negative Pressure Incision Management System vs. Standard Dressing After Vascular Surgery
|
N/A | |
Completed |
NCT02563535 -
Evaluation of the Use of ACOTEC Drug-Eluting Balloon Litos ® in Below-The-Knee Arteries to Treat Critical Limb Ischemia
|
Phase 4 | |
Completed |
NCT02539940 -
Elutax-SV Drug-eluting Balloons for Below-the-knee Treatment
|
||
Completed |
NCT02542267 -
In-Stent Restenosis Post-Approval Study
|
N/A | |
Completed |
NCT02522884 -
Tack Optimized Balloon Angioplasty Study of the Tack Endovascular System™ in Femoropoliteal Arteries
|
N/A | |
Completed |
NCT02262949 -
A Prospective Study of the Bard® LifeStent® Solo Vascular Stent System
|
N/A | |
Completed |
NCT02145065 -
First-in-man Evaluation of a Novel, Microcrystalline Paclitaxel Coated Balloon for Treatment of Femoropopliteal Artery Disease (PAX-r)
|
N/A | |
Completed |
NCT02228564 -
BARD® Study of LIFESTREAM™ Balloon Expandable Covered Stent Treating Iliac Arterial Occlusive Disease
|
N/A | |
Completed |
NCT01743872 -
Optical Imaging Measurement of Intravascular Solution Efficacy Trial
|
N/A | |
Recruiting |
NCT01424020 -
Walking Estimated Limitation Calculated by History - Study 2
|
Phase 4 | |
Active, not recruiting |
NCT01597453 -
NOR-SYS: The Norwegian Stroke in the Young Study
|
N/A |